Hao Pei Selected Research

Biomarkers (Surrogate Marker)

1/2021	Serum Protein N-Glycosylation Signatures of Neuroblastoma.
11/2020	Programming bulk enzyme heterojunctions for biosensor development with tetrahedral DNA framework.
9/2018	Framework Nucleic Acid-Mediated Pull-Down MicroRNA Detection with Hybridization Chain Reaction Amplification.
3/2018	MoS2 Nanoprobe for MicroRNA Quantification Based on Duplex-Specific Nuclease Signal Amplification.
1/2018	Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis.
1/2018	Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma.
1/2016	Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Pei Research Topics

Disease

15	Neoplasms (Cancer) 03/2024 - 01/2011
6	Tuberculosis (Tuberculoses) 01/2016 - 03/2013
4	Pulmonary Tuberculosis 01/2018 - 06/2013
4	Chronic Hepatitis B 12/2012 - 04/2012
3	Infections 01/2022 - 01/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 10/2014
2	Fibrosis (Cirrhosis) 11/2023 - 10/2014
2	Communicable Diseases (Infectious Diseases) 01/2022 - 07/2013
2	Hepatitis C 05/2021 - 10/2014
2	Hepatitis B 05/2021 - 12/2012
2	Neuroblastoma 01/2021 - 01/2018
2	COVID-19 12/2020 - 01/2020
2	Wounds and Injuries (Trauma) 12/2019 - 06/2019
2	Esophageal Squamous Cell Carcinoma 12/2013 - 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023
1	Ulcerative Colitis 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 06/2022
1	Lymphatic Metastasis 06/2022
1	Ascites 06/2022
1	Spinal Tuberculosis (Pott's Disease) 09/2021
1	Liver Neoplasms (Liver Cancer) 05/2021
1	Autoimmune Hepatitis 05/2021
1	Liver Diseases (Liver Disease) 05/2021
1	Fatty Liver 05/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Virus Diseases (Viral Diseases) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2020
1	Myocardial Infarction 01/2020
1	Rupture 10/2019
1	Burns 06/2019
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Acidosis 12/2018
1	Stomach Neoplasms (Stomach Cancer) 09/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2018
1	Pathologic Processes 03/2018
1	Hypersensitivity (Allergy) 01/2014

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 06/2013
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2012
3	CytokinesIBA 01/2023 - 05/2013
3	HydrogelsIBA 12/2019 - 06/2019
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2013
2	EnzymesIBA 01/2023 - 12/2020
2	Interleukin-18 (Interleukin 18)IBA 01/2022 - 05/2021
2	Polysaccharides (Glycans)IBA 01/2021 - 01/2018
2	AntibodiesIBA 12/2020 - 01/2019
2	Nucleic AcidsIBA 12/2019 - 09/2018
2	Capsules (Microcapsules)IBA 10/2019 - 10/2014
2	Immunoglobulin G (IgG)IBA 06/2018 - 01/2018
2	Macrophage Migration-Inhibitory FactorsIBA 01/2018 - 01/2016
2	kurarinolIBA 12/2012 - 04/2012
2	Fc Receptors (Fc Receptor)IBA 12/2012 - 01/2011
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2023
1	Indicators and Reagents (Reagents)IBA 11/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Synthetic Vaccines (Recombinant Vaccines)IBA 12/2022
1	FatsIBA 06/2022
1	InflammasomesIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	MucinsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Therapeutic UsesIBA 06/2021
1	Small Interfering RNA (siRNA)IBA 06/2021
1	InterleukinsIBA 05/2021
1	Mannose (D-Mannose)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Propofol (Diprivan)FDA LinkGeneric 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Sarcosine (Methylglycine)IBA 11/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Troponin IIBA 01/2020
1	CollagenIBA 12/2019
1	GuanosineIBA 12/2019
1	NucleosidesIBA 06/2019
1	AutoantibodiesIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Antinuclear AntibodiesIBA 01/2019
1	Acid Sensing Ion ChannelsIBA 12/2018
1	Immunoglobulin M (IgM)IBA 06/2018
1	CatecholaminesIBA 01/2018
1	human ERBB2 proteinIBA 10/2017
1	peginterferon alfa-2a (Pegasys)FDA Link 10/2014
1	fuzheng huayuIBA 10/2014
1	CytosineIBA 01/2014
1	OligodeoxyribonucleotidesIBA 01/2014

Therapy/Procedure

3	Immunotherapy 12/2022 - 10/2021
3	Therapeutics 12/2019 - 03/2015
1	Blood Transfusion (Blood Transfusions) 09/2021
1	Spinal Fusion (Spondylosyndesis) 09/2021
1	Drug Therapy (Chemotherapy) 12/2019
1	Injections 06/2019
1	Highly Active Antiretroviral Therapy (HAART) 06/2018
1	Photothermal Therapy 01/2018
1	Lasers (Laser) 01/2018
1	Retreatment 03/2017
1	Oral Administration 10/2014